Effect of central venous catheter type on infections: a prospective clinical trial

J Hosp Infect. 2003 May;54(1):10-7. doi: 10.1016/s0195-6701(03)00071-9.

Abstract

This study reports on a block clinical trial of two types of central venous catheters (CVCS): antiseptic-impregnated catheters (AIC) and non-impregnated catheters (non-AIC), on catheter tip colonization and bacteraemia. In total, 500 catheters were inserted in 390 patients over the 18 month study period, 260 (52.0%) AIC and 240 (48.0%) non-AIC. Of these, 460 (92.0%) tips (237 AIC and 223 non-AIC) were collected. While significantly fewer AIC, 14 (5.9%), than non-AIC, 30 (13.5%), catheters were colonized (P<0.01), there was no difference in the rates of bacteraemias in the two groups (0.8% vs. 2.7%, respectively, P=0.16). There were 6.87 (95% CI 3.38-14.26) and 16.92 (95% CI 10.61-27.12) colonized AIC and non-AIC catheters, respectively, per 1000 catheter days, a difference that was significant (P<0.01). However, no difference emerged between bacteraemias in AIC and non-AIC catheters per 1000 catheter days measured at 0.98 (95% CI 0.24-5.54) and 3.38 (95% CI 1.29-9.34), respectively (P=0.10). Of the 444 CVCs that were sited in the subclavian or jugular veins and had tips collected, significantly more catheters were colonized in the jugular group, 19 (20%), compared with the subclavian group, 24 (6.9%; P< or =0.01). Overall, the low rates of colonization and bacteraemia may be explained by the population studied, the policies used and the employment of a clinical nurse dedicated to CVC management.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Anti-Infective Agents, Local / administration & dosage
  • Bacteremia / etiology
  • Bacteremia / microbiology*
  • Bacteremia / prevention & control
  • Catheterization, Central Venous / instrumentation*
  • Catheters, Indwelling / microbiology*
  • Chlorhexidine / administration & dosage
  • Coated Materials, Biocompatible
  • Colony Count, Microbial
  • Cross Infection / etiology
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Equipment Contamination / prevention & control
  • Female
  • Hospital Bed Capacity, 500 and over
  • Humans
  • Infection Control / methods
  • Jugular Veins
  • Male
  • Middle Aged
  • Prospective Studies
  • Queensland
  • Silver Sulfadiazine / administration & dosage
  • Subclavian Vein

Substances

  • Anti-Infective Agents, Local
  • Coated Materials, Biocompatible
  • Chlorhexidine
  • Silver Sulfadiazine